Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,957 total articles
Dycom Industries, Inc. announced the appointment of Regina Salazar as Senior Vice President and Chief Information and Digital Officer. Ms. Salazar brings over 30 years of experience in driving digital transformation and AI-powered initiatives, having served in leadership roles at Novelis, Inc. and Whirlpool Corporation. She will lead Dycom's techno…
Red Cat Holdings' maritime division, Blue Ops, has partnered with HADDY to integrate Agentic AI-powered robotic 3D printing into its Valdosta, Georgia facility. This will double manufacturing capacity and enable faster, more flexible production of Unmanned Surface Vessels (USVs). The collaboration supports rapid iteration and scalable production, a…
Cytokinetics announced its participation in the 25th Annual Needham Virtual Healthcare Conference with a management fireside chat scheduled for April 13, 2026. The company highlighted its specialty in cardiovascular biopharmaceuticals, particularly its approved drug MYQORZO® (aficamten) for obstructive hypertrophic cardiomyopathy and ongoing develo…
urban-gro, Inc. announces its strategic roadmap to enter and monetize the rapidly growing global T20 cricket ecosystem through its recent integration with Flash Sports & Media and Innovative Production Group. The company outlines near-term to long-term catalysts focused on market entry via player drafts, platform monetization, revenue scaling, and …
Invivyd, Inc., a Nasdaq-listed biopharmaceutical company, announced inducement grants of stock options totaling 1,083,750 shares to 16 newly hired non-executive employees. These grants conform to Nasdaq Listing Rule 5635(c)(4) and the company's 2026 Inducement Plan, with options priced at $1.33 per share, vesting over four years, and a 10-year term…
Neumora Therapeutics, a clinical-stage biopharmaceutical company specializing in novel neuroscience therapies, announced its participation in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, with a live webcast available to investors and the public.
Duolingo, leading mobile learning platform, announces it will release its Q1 2026 financial results on May 4, 2026, after U.S. market close, accompanied by a public webcast. The company highlights its position as the most popular language learning app and its continued commitment to innovative education technology.
Sharps Technology transformed its financial position in 2025 by implementing a Solana-based digital asset treasury strategy, accumulating over 2 million SOL, achieving nearly $7 million in staking revenue, and significantly expanding its asset base, while phasing out unprofitable manufacturing operations to create a scalable, capital-efficient busi…
James River Group Holdings, Inc., a specialty insurance holding company, announced its plan to release first quarter earnings after market close on May 4, 2026, followed by a conference call on May 5, 2026. The company operates in specialty property-casualty insurance segments and maintains strong A- ratings from A.M. Best Company.
Celestica Inc. will release its financial results for the first quarter of 2026 after market close on April 27, 2026, followed by a conference call on April 28, 2026. Investors and interested parties can join the live webcast or access a recording afterward.
MidCap Financial Investment Corporation (NASDAQ: MFIC) has scheduled its earnings report for the quarter ended March 31, 2026, to be released after market close on May 6, 2026. The company will host a conference call on May 7, 2026, to discuss results. MidCap Financial is a diversified business development company primarily investing in first lien …
NRx Pharmaceuticals announced the FDA's preliminary alignment on the labeling for its preservative-free ketamine product under its generic drug application, with anticipated approval expected in Summer 2026. This product could help address current ketamine supply shortages in the U.S. and aligns with national priorities on domestic drug manufacturi…
Opus Genetics, a clinical-stage biotech company specializing in gene therapies for inherited retinal diseases, announced a strategic financing agreement with Oberland Capital providing up to $155 million in non-dilutive funding to accelerate clinical development and potential commercialization of its gene therapy pipeline. The initial $35 million t…
Uniti Group Inc. announced it will report its first quarter 2026 financial results on May 11, 2026, before Nasdaq market open, and will hold a conference call that day at 8:30 AM Eastern Time to discuss the earnings. The company provides fiber communications services across the U.S. and offers multiple brands including Uniti Wholesale, Kinetic, Uni…
Agios Pharmaceuticals, a commercial-stage biopharmaceutical company focused on rare diseases, announced it will host a conference call and live webcast on April 29, 2026 to report its Q1 2026 financial results and business updates. The webcast will be accessible via the investor section of the company website, with a replay available shortly after …
Treasure Global Inc. reappoints Sam Teo as Acting CEO to lead the company's next growth phase, focusing on scaling its ZCITY platform, fintech, e-commerce, and emerging technology verticals. Carlson Thow steps down as CEO but remains as Executive Director to support strategic initiatives. The company reports strong user engagement and significant A…
BioCryst Pharmaceuticals appoints Sandeep M. Menon, MD, PhD, as Chief Research and Development Officer to spearhead clinical development and regulatory strategies. This leadership change supports BioCryst's ongoing commercial success with ORLADEYO and advancement of its rare disease therapy pipeline including the recently acquired navenibart progra…
Sagimet Biosciences announced presentations at the Fueling MASH Keystone Symposium detailing analysis from their Phase 2b FASCINATE-2 trial of denifanstat in MASH patients, showing significant reductions in bile acid biomarkers correlated with fibrosis and MASH resolution. Additionally, the company granted inducement options to a new employee under…
Exponent, Inc., a leading engineering and scientific consulting firm, announced key leadership changes effective May 1, 2026. John Pye is promoted to President, bringing extensive technical and leadership experience, while Eric Anderson is appointed CFO, leveraging his financial expertise and operational insight. Additionally, Richard Schlenker wil…
Anterix has secured a significant sale agreement with NorthWestern Energy for the deployment of its 10 MHz broadband configuration in the 900 MHz band, following FCC approval to expand Anterix's broadband spectrum allocation. This deployment enhances mission-critical private wireless connectivity for utilities, enabling improved grid modernization,…
Medicus Pharma Ltd. announced the submission of an optimized Phase 2 clinical study protocol for Teverelix, its investigational GnRH antagonist, to the U.S. FDA. The study targets prevention of recurrent acute urinary retention in men with benign prostatic hyperplasia. The new study design reduces sample size and cost, aiming for rapid generation o…
Neuronetics, Inc., a Nasdaq-listed medical technology company specializing in neurohealth solutions including the NeuroStar Advanced Therapy System, announced the upcoming departure of CFO Steven E. Pfanstiel effective May 1, 2026. The company has initiated a search for his replacement and reaffirmed its previously issued financial guidance for 202…
nCino, Inc. announced significant customer success with its Analyst Digital Partner AI agent, which reduces commercial banking relationship review times from days to hours. The AI agent, built on extensive banking-specific data, allows credit teams to handle reviews 60-70% faster, enabling more frequent and proactive risk management. The solution i…
USCB Financial Holdings, Inc., a Nasdaq-listed bank holding company, announced it will release its first quarter 2026 financial results on April 23, 2026, followed by a conference call with executive leadership to discuss performance. The company operates U.S. Century Bank, a major community bank in Florida.
Glacier Bancorp, Inc. announced it will report its first quarter 2026 financial results on April 23, 2026, followed by an investor conference call on April 24. The company provided details for webcast participation and dial-in instructions. Glacier Bancorp is the parent company of Glacier Bank and several regional bank divisions across the western …
